Objective: The International League Against Epilepsy (ILAE) proposed a classification system for hippocampal sclerosis (HS) based on location and extent of hippocampal neuron loss. The literature debates the usefulness of this classification system when studying memory in people with temporal lobe epilepsy (TLE) and determining memory outcome after temporal lobe resection (TLR). This study further explores the relationship between HS ILAE subtypes and episodic memory performance in patients with TLE and examines memory outcomes after TLR. Methods: This retrospective study identified 213 patients with TLE who underwent TLR and had histopathological evidence of HS (HS ILAE type 1a = 92; type 1b = 103; type 2 = 18). Patients completed the Wechsler Memory Scale3rd Edition prior to surgery, and 78% of patients had postoperative scores available. Linear regressions examined differences in preoperative memory scores as a function of pathology classification, controlling for potential confounders. Fisher's exact tests were used to compare pathology subtypes on the magnitude of preoperative memory impairment and the proportion of patients who experienced clinically meaningful postoperative memory decline. Results: Individuals with HS ILAE type 2 demonstrated better preoperative verbal memory performance than patients with HS ILAE type 1; however, individual data revealed verbal and visual episodic memory impairments in many patients with HS ILAE type 2. The base rate of postoperative memory decline was similar among all 3 pathology groups. Significance: This is the largest reported overall sample and the largest subset of patients with HS ILAE type 2. Group data suggest that patients with HS ILAE type 2 perform better on preoperative memory measures, but individually there were no differences in the magnitude of memory impairment. Following surgery, there were no statistically significant differences between groups in the proportion of patients who declined. Future research should focus on quantitative measurements of hippocampal neuronal loss, and multicenter collaboration is encouraged.
| INTRODUCTION
Hippocampal sclerosis (HS), the most common pathological substrate in temporal lobe epilepsy (TLE), is marked by neuronal cell loss and gliosis in any hippocampal region, including the dentate gyrus (DG). 1 To help facilitate the study of HS and surgical outcomes following cortical resection for treatment of pharmacoresistant epilepsy, the International League Against Epilepsy (ILAE) proposed a HS classification system. 1 HS ILAE type 1, the most frequently observed HS type, is broken down into 2 subgroups: type 1a, classic HS, marked by severe neuronal loss in hippocampal subregions CA1 > CA4 and CA3 with relative sparing in the CA2 region and type 1b, severe HS, marked by substantial neuronal loss in all hippocampal subsectors CA1-CA4. [1] [2] [3] Both HS ILAE type 1 subtypes typically involve some granule cell loss within the DG. HS ILAE type 2, apparent in 5%-10% TLE cases, presents with severe neuronal loss predominantly within CA1. 1 HS ILAE type 3, diagnosed in 4%-7% of all TLE surgical cases, presents with severe cell loss primarily in CA4 and DG. 1 Finally, the ILAE classification includes a fourth group in which reactive gliosis is noted without neuronal cell loss, which is called "no HS with gliosis only." 1 HS has long been associated with episodic memory impairments in patients with TLE as well as better prognosis for memory outcome following temporal lobectomy. 4, 5 Although many studies over the years have examined the relationship between hippocampal cell loss/ density and memory ability, [6] [7] [8] [9] [10] [11] [12] little is known about episodic memory ability/outcomes as they pertain to the HS pathology subtypes outlined in the ILAE Consensus guidelines. 1 Initial research has suggested that TLE patients with type 2 pathology have intact preoperative memory ability that is comparable to that of patients with nonlesional TLE and significantly better than performance of individuals with types 1 or 3. 13 Furthermore, some data suggest that type 2 pathology is overrepresented among patients with left TLE and intact word list learning scores 14 ; however, cases of type 2 with episodic memory deficiencies have also been documented. 11, 15 Further, there is evidence to suggest that overall degree of neuronal loss may be a more important factor in episodic memory performance than the pattern of cell loss or the hippocampal subregions within which neuronal loss occurs. 10, 15 The limited data available regarding HS ILAE subtype and memory outcome following epilepsy surgery have been conflicting. One study found greater postoperative memory decline in patients with type 2 pathology, 13 but a subsequent study failed to replicate this finding. 15 The goal of the current study was to further explore the relationship between HS ILAE subtypes and episodic memory performance/outcome in an independent sample of patients with TLE who underwent temporal lobectomy for treatment of pharmacoresistant epilepsy.
| METHODS

| Participants
Data for this retrospective study were obtained from an institutional review board-approved neuropsychology registry containing demographic, cognitive, seizure, and surgical variables for patients with pharmacoresistant epilepsy who were being evaluated for potential surgery. Patients were included in the study if they met the following criteria: (1) age 16 years or older; (2) history of temporal lobe epilepsy; (3) had undergone anterior temporal lobe resection that included removal of the hippocampus; (4) had histopathological evidence of hippocampal sclerosis; (5) did not have a second, independently epileptogenic lesion (other than focal cortical dysplasia); (6) had no history of epilepsy surgery; and (7) had completed a comprehensive preoperative neuropsychological evaluation that included the Wechsler Memory Scale-Third Edition (WMS-III).
A total of 213 patients met all study criteria. Most of the patients were Caucasian and female (94% and 56%, respectively). Patients ranged in age from 16 to 73 years (mean 39.8, standard variation [SD] 12.4) and had 6-20 years of education (mean 12.9, SD 2.2). Mean age at seizure onset was 15.5 years (SD 12.4) and average duration of epilepsy was 24.3 years (SD 15.2). Mean Full Scale IQ was in the average range (mean 90.5; SD 13.7). Surgical resection side was classified as dominant (n = 108) or nondominant (n = 105) based on handedness and/or results of a language lateralization procedure (ie, functional magnetic resonance imaging [fMRI] or Wada test). Fifty-five patients had Wada testing and 11 patients underwent fMRI. Of these, 9 (14%) showed right-sided language dominance.
Key Points
• The ILAE has classified HS by location/severity of neuronal loss
• Patients with predominant cell loss in CA1 (HS ILAE type 2) demonstrated better group memory performance than those with more widespread abnormalities
• Individual data revealed episodic memory impairments in many patients, regardless of classification
• Postoperative memory outcomes were similar among all pathology subtypes For these individuals, right-sided resections were considered dominant.
A subset of 166 patients (78% of overall sample) completed a second neuropsychological evaluation following surgery (HS ILAE type 1a = 78, type 1b = 73, or type 2 = 15). This patient subset was comparable to those who did not return for postoperative neuropsychological testing on all demographic and disease variables, except for age. Specifically, the subset of patients who completed postoperative testing were younger than those who did not (38.5 vs 44.2). Postoperative seizure outcomes were comparable among the 3 pathology groups, with 83.7% of patients completely free of seizures at the time of their neuropsychological follow-up.
| Measures
The WMS-III was used to assess verbal and nonverbal episodic memory before and after surgery. The following age-adjusted subscale scores (both immediate and delayed trials) were included in the analyses: Logic Memory (LM), Faces (FA), Verbal Paired Associates (VPA), and Family Pictures (FP). Preoperative scaled scores (M 10, SD 3) were used in regression analyses (see Statistical analyses section below). To assess the magnitude of memory impairment at the individual patient level, preoperative scores were also classified as intact (scaled score >7), moderately impaired (scaled score 1 SD below the normative mean; ie, 5-7), or severely impaired (scaled score 2 SD or more below the normative mean; ie, 4 or below). To assess clinically meaningful cognitive change following epilepsy surgery, published reliable change indices (RCIs; 90% confidence interval [CI]) 16 were used to categorize individual patient outcomes (decline vs no decline) on each of the WMS-III memory subtests. Study participants completed preoperative testing an average of 3.8 months (SD 6.3) before surgery. Among the subset of patients who returned after surgery, postoperative testing was completed an average of 8.1 months (SD 7.8) after surgery and 12.2 (SD 8.7) months after the preoperative evaluation. The average retest interval in the current study was longer than the 7.5 month (SD 3.3) average retest interval used by Martin et al 16 studies that have characterized cognitive outcome using these RCIs.
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| Pathological classification
One neuropathologist (RP) used a semi-quantitative approach to classify hippocampal sclerosis subtype according to the 2013 ILAE Consensus Guidelines, 1 using antibodies to glial fibrillary acidic protein (GFAP) (1:600 dilution, DAKO, Carpinteria, CA, USA) and neuN (1:800 dilution, Millipore, Princeton, NJ, USA) in select cases. Patients presenting with HS ILAE type 1a pathology had severe neuronal loss in CA1, CA3, and CA4 (n = 92; 43.2%; Figure 1A ). Patients with HS ILAE type 1b pathology presented with severe neuronal loss in all subsectors CA1-CA4 (n = 103; 48.4%; Figure 1B ). Patients with HS ILAE type 2 pathology had neuronal loss restricted to the CA1 region (n = 18; 8.5%; Figure 2 ). No patients in this cohort were classified as having HS ILAE type 3, or no-HS.
| Statistical analyses
Descriptive statistics were calculated for the entire sample and for the sample stratified by HS ILAE subtype. Oneway analysis of variance and chi-square or Fisher's exact tests were used to compare pathology subtypes on demographic and disease variables. Simple linear regression analyses were used to assess differences in preoperative memory subtest scores as a function of pathology classification and to examine relationships between potential confounders and the independent and dependent variables of interest. The following potential covariates were examined: age at seizure onset, disease duration in years, seizure side (dominant vs nondominant), bilateral HS on MRI, Full Scale IQ, sex, dual pathology (HS vs HS plus focal cortical dysplasia), and seizure outcome (seizure-free vs not seizure-free, considered for postoperative analyses only). To control for confounding effects, covariates found to be significantly associated with both pathology subtype and memory subtest score were included in the final multiple linear regressions. Given that TLE is associated with material-specific deficits, a seizure side (dominant vs nondominant) by HS ILAE subtype interaction term was tested for each multiple linear regression and included if statistically significant. Model fit was evaluated by plotting the error term against the outcome. Fisher's exact tests were used to compare pathology subtypes according to the magnitude of preoperative memory impairment and to determine whether pathology groups differed in the proportion of patients who experienced clinically meaningful postoperative decline as indicated by RCIs. 16 Analyses were conducted using SAS Studio 3.5 (SAS, Cary, NC, USA) and were two-tailed with alpha set to .05.
T A B L E 1 Demographic and disease variables by HS ILAE type
| RESULTS
| Pathology group differences
Group differences were seen in age at preoperative cognitive testing, age at seizure onset, and patient sex. On average, individuals with HS ILAE type 1b pathology were older than those with type 1a pathology in both age at preoperative testing and age at seizure onset, averaging 5.5 years and 4.7 years older, respectively. More males than females were diagnosed with type 1b (52.4%), whereas more females than males were diagnosed with type 1a and type 2 (62.0% and 77.8%, respectively). There were no group differences on other demographic or disease variables (Table 1) .
| Baseline performance
Before accounting for confounders, patients diagnosed with HS ILAE type 2 scored significantly higher than patients diagnosed with type 1a on LM Immediate (b = 1.66, t 1 = 2.53, P = .036), VPA Immediate (b = 1.8, t 1 = 2.53, P = .024), LM Delayed (b = 1.68, t 1 = 2.53, P = .045), and VPA Delayed (b = 1.81, t 1 = 2.53, P = .028). Patients with HS ILAE type 2 scored higher than those with type 1b on VPA Immediate (b = 1.85, t 1 = 2.53, P = .019) and VPA Delayed (b = 1.81, t 1 = 2.53, P = .026).
Sex was included as a covariate in models assessing VPA, and sex and age at seizure onset were included in models assessing LM. No other covariates of interest were significantly associated with both pathology subtype and any memory test outcome. The seizure side (dominant vs nondominant) by HS ILAE subtype interaction term was neither significant nor included for any model. When controlling for the confounding effects of sex and age at seizure onset, patients with HS ILAE type 2 scored significantly higher than those with type 1a on LM Immediate (b = 1.58, t 1 = 2.06, P = .041). When controlling for the confounding effect of sex, patients diagnosed with HS ILAE type 2 scored higher than those with type 1a on VPA Immediate (b = 1.64, t 1 = 2.09, P = .038) and VPA Delayed (b = 1.65, t 1 = 2.04, P = .043; Figure 3 ).
There were no significant differences in the proportion of patients with intact, moderately impaired, or severely impaired preoperative memory performance (Figure 4) . proportion was not significant for LM Delayed. There were no statistically significant differences between pathology groups in the proportion of patients who were classified by RCIs as having declined postoperatively (Table 2 ).
| DISCUSSION
Results of the current study suggest that patients with neuronal cell loss primarily restricted to the CA1 region of the hippocampus (HS ILAE type 2) demonstrate better preoperative verbal memory performance than those with more widespread cell loss in the CA1, CA3, and CA4 regions (HS ILAE type 1a). Specifically, patients with HS ILAE type 2 pathology scored an average of 1.6 scaled score points higher on verbal memory subtests than those with type 1a pathology. Few studies in the literature have examined baseline episodic memory performance as a function the new HS ILAE subtype classification. The first investigation, conducted by Coras et al, 13 used a composite verbal memory score derived from structured and unstructured list learning tasks. Their findings suggested that patients with HS ILAE type 2 pathology did not have declarative memory dysfunction and, in fact, had mean scores resembling patients with no HS. Although results in our independent sample also show higher memory scores among patients with HS ILAE type 2 pathology as compared to type 1, the mean scores of patients with type 2 pathology were below the normative mean of 10. This discrepant finding may be due to differences in sample characteristics. Although the Coras sample was demographically similar to the patients in our cohort, their sample had less severe disease, as they excluded patients with bilateral temporal lobe epilepsy or bilateral memory impairment. Furthermore, the surgery types in their sample varied from selective amygdalohippocampectomy to anterior temporal lobectomy, while all patients in our cohort had standard anterior temporal lobe resections. Finally, discrepant findings may also be due to differences in memory test paradigms (ie, list learning vs story recall and word-pair learning). Although patients with HS ILAE type 2 pathology have higher mean memory scores overall, examining mean group differences can mask potentially important information. When we examined individual preoperative test scores and associated degree of memory impairment in our sample, the proportion of intact and moderate and severe deficits was not different between HS ILAE subtypes. In fact, a substantial proportion (ie, 44%) of patients with pathology restricted to the CA1 region (HS ILAE type 2) had moderate to severe impairments on 2 or more of the WMS-III subtests before surgery. This finding is consistent with 2 recent studies that reported a high percentage of verbal and visual memory deficits among individual patients with type 2 pathology 15, 20 and in line with a host of studies that have shown a relationship between episodic memory and neuronal cell densities in the CA1 region of the hippocampus. 8, 21, 22 Following temporal lobectomy, we found little difference in the base rate of memory decline between the 3 pathology subgroups, which is consistent with the recent findings of Jardim et al. 15 Only one other study in the literature has examined postoperative memory outcomes using the HS ILAE classification to stratify groups. Coras et al 13 found a marked postoperative decline in mean verbal memory performance among HS ILAE type 2 patients in their cohort; however, they did not examine individual memory outcomes using reliable change indices, which may account for the discrepant findings. Limitations of our study include the small sample size of individuals with HS ILAE type 2 pathology, the absence of patients with type 3 pathology, a lack of quantitative data regarding neuronal cell loss in the various regions of the hippocampus, and the lack of a control group of patients with no HS. Nevertheless, this study includes the largest overall sample (n = 213) and the largest subset of patients with HS ILAE type 2 pathology (n = 18) reported to date. Given the low prevalence of HS ILAE type 2 and type 3 pathologies, thorough examination of this topic will require multicenter collaboration with detailed pathological phenotyping and examination of both group and individual performances/outcomes.
In summary, the current study examined episodic memory performance before and after epilepsy surgery in an independent cohort of patients with TLE. Findings confirm that patients with HS ILAE type 2 pathology demonstrate better group memory performance than those with type 1 pathologies; however, this does not imply that individual patients with restricted CA1 cell loss do not have impairments in episodic memory (a substantial proportion of individual patients demonstrated impairments on both verbal and visual memory tests) or that they are at increased risk for memory decline following temporal lobectomy (the proportion of patients who experience postoperative memory declines are similar to those observed among patients with HS ILAE type 1 pathologies).
